Aryl-Cyclohexanone as a Potential CB2 Agonist: In Vitro and In Silico Evidence in Inflammatory Modulation.
Aryl-cyclohexanone cb2 agonist shows promise as a selective anti-inflammatory agent. This synthetic compound reduces inflammatory markers and supports immune modulation. Current evidence is preclinical, highlighting potential for future therapeutic…
Leukemia Study Restores Silenced Gene in Mice: Potential Treatment Implications
Leukemia gene silencing research has restored a silenced gene in mice, shedding light on potential new treatments. This preclinical study focuses on epigenetic mechanisms in leukemia. Understanding these mechanisms may inform future therapeutic…
THC and CBD Induce Cell Death via Heme Oxygenase-1 in Skin Cancer Cells
Cannabinoids skin cancer research reveals that THC and CBD induce cell death through heme oxygenase-1 pathways. This study highlights mitochondrial dysfunction in melanoma and squamous carcinoma cells. These findings provide early mechanistic insight…
Loss of dystrophin reduces CB1 receptor expression and endocannabinoid-dependent synaptic plasticity in the cerebellar cortex.
Dystrophin endocannabinoid system disruption reduces CB1 receptor expression in the cerebellar cortex. This affects endocannabinoid-dependent synaptic plasticity, relevant to Duchenne Muscular Dystrophy. Understanding this mechanism may inform future…
Cannabidiol Reduces Early-Stage Inflammation in Rat Adipose Tissue
This CBD obesity inflammation study investigates cannabidiol's impact on fat tissue inflammation in rats. The research highlights CBD's potential to reduce lipid accumulation and inflammatory markers. Findings suggest tissue-specific effects in visceral…
Unraveling Endocannabinoid Signaling Pathways in Cisplatin-Induced Ototoxicity
Cisplatin-induced ototoxicity is a detrimental side effect of chemotherapy leading to hearing loss, for which no treatments are currently available. This study reveals the presence of endocannabinoid signaling pathways in auditory hair cells affected by…
Delta-9-Tetrahydrocannabinol alleviates chemotherapy-induced weight loss but not colitis
Delta-9-tetrahydrocannabinol weight loss effects were studied in a preclinical model showing benefits against chemotherapy-induced weight loss. This research highlights THC's potential in managing weight loss during chemotherapy. However,…
Exploring CBD as a Prophylactic Agent Against Glioblastoma Growth
This CBD glioblastoma preclinical study examines cannabidiol's potential to reduce tumor growth in glioblastoma. The research shows prolonged CBD exposure may modulate immune and tumor markers. While promising, these findings are preliminary and require…
CB2R-mediated GPX4 Stabilization: A New Avenue for Treating Cognitive Impairment in Elderly Migraine Patients
CB2 receptor cognitive impairment research highlights a novel mechanism for protecting brain function in migraine patients. Stabilizing GPX4 via CB2R activation may prevent neuronal damage linked to ferroptosis. This emerging approach offers hope for…
Cannabigerol Induces ER Stress-Mediated Apoptosis and Ferroptosis in Pancreatic Cancer
Cannabigerol pancreatic cancer cells research reveals dual mechanisms of cell death: apoptosis and ferroptosis. This study highlights the role of endoplasmic reticulum stress via the IRE1α-XBP1 axis. These findings provide promising preclinical insights…